WO2023213660 - CRISPR-BASED MODIFICATION OF HUMAN HBD GENE
National phase entry:
Publication Number
WO/2023/213660
Publication Date
09.11.2023
International Application No.
PCT/EP2023/061017
International Filing Date
26.04.2023
Title **
[English]
CRISPR-BASED MODIFICATION OF HUMAN HBD GENE
[French]
MODIFICATION À BASE DE CRISPR DU GÈNE HBD HUMAIN
Applicants **
ETH ZURICH
Raemistrasse 101 / ETH transfer
8092 Zurich, CH
Inventors
CORN, Jacob
In der Hub 12
8057 Zürich, CH
BOONTANRART, Mandy
Schaffhausestrasse 124
8057 Zürich, CH
Priority Data
22171430.6
03.05.2022
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1403 | |
| EPO | Filing, Examination | 5408 | |
| Japan | Filing | 591 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 3310 |
Total: 11287 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
gene.[French]
La présente invention se rapporte au domaine de l'édition génomique à base de CRISPR. L'invention concerne des acides nucléiques, des compositions et des kits pour l'édition d'un gène HBD humain et leur utilisation dans le traitement d'hémoglobinopathies. L'invention concerne en outre des procédés de fabrication de ceux-ci et des procédés d'édition d'un gène HBD humain.